Work by our laboratory and others has demonstrated that silencing of PGAM5 attenuates cell growth, reduces cellular ATP levels, and dysregulates lipid metabolism in cell-based and in vivo models of HCC [3,6,12,13]. Here, PGAM5 is linked to hepatocellular carcinoma.